Boston Scientific (BSX) Income from Non-Controlling Interests (2023 - 2026)
Boston Scientific recorded quarterly Income from Non-Controlling Interests of -$2.0 million in Q1 2026, little changed quarter-over-quarter from -$2.0 million in Q4 2025, and little changed year-over-year from -$2.0 million in Q1 2025.
Boston Scientific's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$2.0 million for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests changed 0.0% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$6.0 million (up 25.0% YoY), while the FY2025 annual figure was -$6.0 million, up 25.0% from the prior year.
- Income from Non-Controlling Interests came in at -$2.0 million for Q1 2026 at Boston Scientific, roughly flat from -$2.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$1.0 million in Q4 2023 to a low of -$4.0 million in Q4 2024.
- A 4-year average of -$2.0 million and a median of -$2.0 million in 2024 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests tumbled 300.0% in 2024 and surged 50.0% in 2025, its largest moves.
- Boston Scientific's Income from Non-Controlling Interests stood at -$1.0 million in 2023, then sank by 300.0% to -$4.0 million in 2024, then soared by 50.0% to -$2.0 million in 2025, then changed by 0.0% to -$2.0 million in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$2.0 million, -$2.0 million, and -$2.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |